Strategy for treatment of stage IV human epidermal growth factor 2-positive gastric cancer: a case report

BACKGROUND: The prognosis of stage IV gastric cancer and human epidermal growth factor 2 (HER2)-positive gastric cancer is poor, although new drugs and regimens have been developed. We report a case of a patient with stage IV HER2-positive gastric cancer treated successfully by conversion therapy an...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakaguchi, Masazumi, Shimoike, Norihiro, Akagawa, Shin, Kanaya, Seiichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385396/
https://www.ncbi.nlm.nih.gov/pubmed/30791934
http://dx.doi.org/10.1186/s13256-019-2001-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385396/
https://www.ncbi.nlm.nih.gov/pubmed/30791934
http://dx.doi.org/10.1186/s13256-019-2001-3

Ejemplares similares